3.96
-0.28 (-6.6%)
-0.28 (-6.6%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 334,820 |
|
|||||
| News | - | ||||||
| Day High | 4.25 | Low High |
|||||
| Day Low | 3.96 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Provention Bio Inc | PRVB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.28 | -6.6% | 3.96 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.25 | 3.96 | 4.25 | 3.96 | 4.24 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,804 | 334,820 | $ 4.07 | $ 1,364,176 | - | 3.40 - 9.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:01 | 5 | $ 3.96 | USD |
Period:
Draw Mode:
Provention Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 253.60M | 64.04M | 58.41M | $ 1.40M | $ - | -1.81 | -2.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 267.00k | 10.50% |
Provention Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRVB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.89 | 4.50 | 3.81 | 4.15 | 877,189 | 0.07 | 1.8% |
| 1 Month | 4.18 | 4.73 | 3.5416 | 4.03 | 710,627 | -0.22 | -5.26% |
| 3 Months | 7.19 | 7.31 | 3.5416 | 4.51 | 579,856 | -3.23 | -44.92% |
| 6 Months | 6.06 | 8.04 | 3.40 | 5.23 | 799,486 | -2.10 | -34.65% |
| 1 Year | 9.42 | 9.70 | 3.40 | 5.94 | 790,713 | -5.46 | -57.96% |
| 3 Years | 11.28 | 20.05 | 3.40 | 9.81 | 889,960 | -7.32 | -64.89% |
| 5 Years | 8.00 | 22.82 | 1.52 | 9.87 | 741,825 | -4.04 | -50.5% |
Provention Bio Description
| Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-6527, PRV-300, and PRV-101. |